Articles

When compared with other racial and ethnic groups across cancer subtypes, black women with breast cancer have significantly poorer survival, according to a recent study. Read More ›

In the first study of its kind to examine the human genome for predictors of chemotherapy side effects, researchers isolated gene variations with the potential to cause chemotherapy-induced peripheral neuropathy in patients. Read More ›

According to recent study results, women aged 75 years and older were at an increased risk for breast cancer mortality when an extended period of time existed between their last mammogram and a breast cancer diagnosis. Read More ›

Many women whose breast cancer expresses the hormones estrogen or progesterone are recommended a daily intake of tamoxifen or aromatase inhibitors for 5 years. Read More ›

Patients receiving chemotherapy often experience chemotherapy-induced peripheral neuropathy that for up to 40% of patients may persist for months or years following chemotherapy treatments. Read More ›

A recently published study shows that when treating prostate cancer, intermittent androgen deprivation therapy is not as beneficial as continuous androgen deprivation. Read More ›

New retrospective study results show that amiodarone, a widely used arrhythmia medication, may increase the risk of developing cancer. Read More ›

On average, African American men experience a longer wait time between prostate cancer diagnosis and treatment than do Caucasian men. Read More ›

The increased cancer survival population will offer distinctive healthcare challenges in the future. Read More ›

Breast cancer mortality may also be greater for those patients taking combined hormone therapy. Read More ›